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Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits epithelial Na channels (ENaC). Evidence has
accumulated that both Cl3 transport through CFTR Cl3 channels and the first nucleotide binding domain (NBF1) of CFTR
are crucial for inhibition of ENaC. A PDZ binding domain (PDZ-BD) at the C-terminal end links CFTR to scaffolding and
cytoskeletal proteins, which have been suggested to play an important role in activation of CFTR and eventually inhibition
of ENaC. We eliminated the PDZ-BD of CFTR and coexpressed Na/H-exchange regulator factors together with CFTR
and ENaC. The results do not support a role of PDZ-BD in inhibition of ENaC by CFTR. However, inhibition of ENaC was
closely linked to Cl3 currents generated by CFTR and was observed in the presence of Cl3, I3 or Br3 but not gluconate.
Therefore, functional NBF1 and Cl3 transport are required for inhibition of ENaC in Xenopus oocytes, while the PDZ-BD is
not essential. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The cystic ¢brosis transmembrane conductance
regulator (CFTR) is a cAMP regulated Cl3 channel
and a regulator of other channels [1]. The best exam-
ined and pathophysiologically probably most rele-
vant example is the inhibition of amiloride sensitive
epithelial Na channels (ENaC) by CFTR [1]. Due
to the CFTR defect and the lack of inhibition of
ENaC, amiloride sensitive Na transport is enhanced
in both airways and colon of CF patients [2^4].
However, in other epithelial tissues such as the sweat
duct, the situation is remarkably di¡erent. Here,
CFTR has been demonstrated to act as an activator
rather than an inhibitor of ENaC channels [5]. The
reasons for these obviously tissue speci¢c e¡ects of
CFTR on ENaC remain currently unknown. Recent
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results suggest participation of additional proteins in
the CFTR/ENaC interaction. These unknown pro-
teins might be expressed di¡erentially in colon, air-
ways and sweat duct, thereby generating tissue spe-
ci¢c regulatory relationships.
It has been shown previously that CFTR contains
a common site for protein interaction at the very C-
terminal end of the protein, a so called PDZ binding
domain (PDZ-BD). Binding of regulatory proteins to
this C-terminal end of CFTR like the Na/H-ex-
change regulator factor (EBP50, NHERF1,
NHERF2) has been demonstrated [6]. This PDZ do-
main has been shown to be essential for proper ex-
pression of CFTR in the apical plasma membrane
[7,8]. CFTR is anchored in the apical membrane
via cytoskeletal interaction using the ezrin binding
phosphoprotein EBP50 [9]. Moreover, ezrin may
function as an A kinase anchoring protein thereby
linking protein kinase A to CFTR which is essential
for protein kinase A (PKA) mediated phosphoryla-
tion and activation of CFTR [10]. The NHERF1
homologue E3KARP (NHERF2, TKA-1, SIP-1) me-
diates the association of ezrin and PKA with CFTR
in airway cells [11]. Both NHERF1 and NHERF2
have been shown recently to bind to L2-adrenergic
receptors as well as P2Y receptors and may therefore
be multifunctional adopter proteins essential for in-
tracellular signaling [12]. These results suggest that
NHERF proteins might also participate in the regu-
lation of ENaC by CFTR. We therefore examined
whether the presence of an intact C-terminal CFTR
PDZ-BD is essential for activation of CFTR and the
interaction with ENaC in Xenopus oocytes.
Apart from the inhibition of ENaC, CFTR has
been demonstrated to interact with a diversity of
other membrane conductances [13,14]. For some of
these interactions, the requirement of an intact ¢rst
nucleotide binding domain of CFTR has been dem-
onstrated [15^17]. In the present paper we show that
inhibition of ENaC largely depends on the CFTR
Cl3 current, which is activated during stimulation
of CFTR. Using a number of CFTR ¢rst nucleotide
binding domain (NBF1) mutants, we show that
downregulation of ENaC does not take place in the
absence of CFTR Cl3 channel activity. Both proper-
ties of CFTR, namely that of a Cl3 channel and
a regulator of ENaC, are therefore intimately re-
lated.
2. Materials and methods
2.1. cRNAs of NHERF1, NHERF2, ENaC and
CFTR
cDNAs encoding mouse NHERF1 and human
NHERF2 (TKA-1) were kindly obtained from
Prof. Dr. E. Weinman, University of Maryland,
USA and Prof. Dr. A. Ullrich, Max Planck Institut,
Martinsried, Germany. The three (K, L, Q) subunits
of the rat amiloride inhibitable Na channel ENaC
were kindly provided by Prof. Dr. B. Rossier, Phar-
macological institute of Lausanne, Switzerland. The
triple mutant NHERF1-S288/290/291A and the trun-
cation NHERF1-E130X were generated by standard
polymerase chain reaction (PCR) techniques. Using
similar PCR techniques, the NBF1 mutants of hu-
man CFTR vF508, G551D, S466L, K464A, D572N,
KH483/484AA, R487Q, R516A, KR598/600GA,
KK611/612AA and K615A were in vitro synthesized
(Quickchange, Stratagene). Proper sequences were
con¢rmed by automatic sequencing (Big Dye Se-
quencing Kit). cDNAs encoding mutant and wild
type (wt) NHERF1, NHERF2, CFTR and ENaC
were linearized at the 3P end using KpnI, HindIII,
XhoI, NotI and HpaI and were in vitro transcribed
using SP6, T3 and T7 polymerases and a 5Pcap
(mMessage mMachine, Ambion, USA).
2.2. Expression in Xenopus oocytes
Isolation and microinjection of oocytes have been
described in a previous report [15]. In brief, after
isolation from adult Xenopus laevis female frogs
(Xenopus Express, Cape Town, South Africa) oocytes
were dispersed and defolliculated by a 0.5 h treat-
ment with collagenase (type A, Boehringer, Ger-
many). Subsequently, oocytes were rinsed and kept
in ND96 bu¡er (in mmol/l) : NaCl 96, KCl 2, CaCl2
1.8, MgCl2 1, HEPES 5, Na-pyruvate 2.5, pH 7.55,
supplemented with theophylline (0.5 mmol/l) and
gentamicin (5 mg/l) at 18‡C. Oocytes were injected
with cRNA (1^10 ng) after dissolving cRNA in
about 50 nl double distilled water (PV830 pneumatic
pico pump, WPI, Germany). Oocytes injected with
50 nl double distilled water served as controls. Two
to four days after injection oocytes were impaled
with two electrodes (Clark instruments) which had
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a resistance of 1 M6 when ¢lled with 2.7 mol/l KCl.
A £owing (2.7 mol/l) KCl electrode served as bath
reference in order to minimize junction potentials
and had a resistance of 700 6. Membrane currents
were measured by voltage clamping of the oocytes
(OOC-1 ampli¢er, WPI, Germany) in intervals be-
tween 380 and +40 mV in steps of 20 mV for 1 s.
Current data were ¢ltered at 400 Hz (OOC-1 ampli-
¢er). Between intervals, oocytes were voltage
clamped to 310 mV for 5 s. Data were collected
continuously on a computer hard disk at a sample
frequency of 1000 Hz and were analyzed using the
programs chart and scope (McLab, AD-Instruments,
Macintosh). During the experiments the bath was
continuously perfused at a rate of 5^10 ml/min. All
experiments were conducted at room temperature
(22‡C). Whole cell conductances generated by
CFTR (GCFTR) upon stimulation of the oocytes
with 3-isobutyl-1-methylxanthine (IBMX; 1 mmol/l)
and forskolin (2 Wmol/l) were determined in the pres-
ence of amiloride (10 Wmol/l). Amiloride sensitive
conductance (GAmil) was determined by subtracting
the whole cell conductance determined in the pres-
ence of amiloride from the total conductance.
2.3. Materials and statistical analysis
All used compounds were of highest available
grade of purity. IBMX, forskolin, and amiloride
were all from Sigma (Deisenhofen, Germany). Iono-
mycin was from Calbiochem (Australia). NaBr, NaI,
and gluconate were obtained from Merck (Darm-
stadt, Germany). Paired or unpaired Student’s t-test
and analysis of variance were used for statistical
analysis. P values 6 0.05 were accepted to indicate
statistical signi¢cance (*).
3. Results
3.1. The C-terminal PDZ-BD of CFTR is not
required for activation of CFTR or inhibition of
ENaC in Xenopus oocytes
The PDZ-BD at the C-terminal end of CFTR was
mutated in vitro (L1480V-CFTR) and coexpressed
together with the epithelial Na channel in Xenopus
oocytes. Amiloride sensitive whole cell currents were
assessed before and after stimulation of CFTR by
IBMX (1 mM) and forskolin (2 WM). As demon-
strated in Figs. 1 and 2, Na currents inhibited by
amiloride were largely reduced after stimulation of
CFTR. Stimulation of oocytes expressing only
ENaC did not change amiloride sensitive ENaC con-
ductance (data not shown). A Cl3 conductance
(GCFTR) of similar magnitude was activated in both
wtCFTR and L1480V-CFTR expressing oocytes
upon stimulation with IBMX and forskolin (I/F).
The inhibition of ENaC (GAmil) during activation
of CFTR was comparable for wt and mutant
CFTR (Fig. 2B). A truncated version of CFTR
was expressed, comprising the ¢rst transmembrane
spanning domain, the ¢rst nucleotide binding do-
main and the R domain (E831X-CFTR). When
stimulated with I/F, truncated CFTR generated a
whole cell conductance which was signi¢cantly re-
duced when compared to wtCFTR. Nevertheless, a
small but signi¢cant portion of GAmil was inhibited
during stimulation of E831X-CFTR (Fig. 2). In ad-
dition, we generated a CFTR mutant which only
lacks the last six amino acids, encoding the PDZ-
BD (E1474X-CFTR). Much to our surprise,
Fig. 1. Original recordings of the whole cell currents measured
in a Xenopus oocyte coexpressing L1480V-CFTR and ENaC.
E¡ect of amiloride before (A) and after (B) stimulation with
IBMX (1 mM) and forskolin (2 WM). Oocytes were voltage
clamped in intervals from 390 to +30 mV.
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E1474X-CFTR generated a signi¢cantly larger cur-
rent than wtCFTR and largely downregulated GAmil
(Fig. 2). In fact, downregulation of ENaC was sig-
ni¢cantly enhanced when compared to wtCFTR,
which is likely due to the large Cl3 conductance
generated by E1474X-CFTR. These results clearly
indicate that the C-terminal PDZ-BD of CFTR is
required neither for activation of CFTR nor for
CFTR mediated inhibition of ENaC in Xenopus oo-
cytes.
We further ruled out a role of PDZ-BD in the
inhibition of ENaC, by coexpressing NHERF1 and
NHERF2 with ENaC and CFTR. NHERF1 and
NHERF2 have been demonstrated to interact with
the CFTR PDZ-BD [6,11]. Coexpression of
NHERF1 (n = 8) or NHERF2 (n = 12) with only
ENaC had no impact on the magnitude of the Na
conductance expressed in the oocytes and did not
confer any cAMP sensitivity to ENaC (data not
shown). GCFTR was activated by IBMX and forskolin
(Fig. 3, gray bars), in the presence of NHERF1 or
NHERF2. When compared with CFTR Cl3 conduc-
tance in the absence of NHERF (GH2O), the magni-
tude was similar in the presence of the various
NHERF constructs (Fig. 3). GAmil was detected
under all experimental conditions and was
35.6 þ 3.5 WS (GH2O), 71.3 þ 6.3 WS (GNHERF1),
33.3 þ 3.1 WS (GNHERF1ÿE130X), 37.5 þ 3.7 WS
(GNHERF1ÿS288=290=291A), and 30.7 þ 2.9 WS (GNHERF2)
(Fig. 3). Moreover, CFTR was still able to down-
regulate ENaC in the presence of NHERF1 or
NHERF2 and the downregulation was similar in
the absence or presence of NHERF (% inhibition,
black bars in Fig. 3). We further examined whether
elimination of the putative phosphorylation domains
in NHERF1 (NHERF1-S288/290/291A) or deletion
of the second PDZ (PDZ2) domain of NHERF1
(NHERF1-E130X) impairs regulation of ENaC by
CFTR. However, both mutants had no impact on
activation of CFTR or inhibition of ENaC by
CFTR. Thus, the PDZ domain proteins NHERF1
and NHERF2, which presumably interact with the
CFTR PDZ-BD [11], have no impact on activation
of CFTR or inhibition of ENaC by CFTR in Xeno-
pus oocytes.
Fig. 2. Coexpression of wtCFTR, L1480V-CFTR, E831X-
CFTR and E1474X with ENaC. Summary of CFTR Cl3 con-
ductances (GCFTR) *Signi¢cant changes in activation of GCFTR
when compared with wtCFTR (A) and amiloride sensitive
whole cell conductances (GAmil) (B) before and after stimulation
with IBMX and forskolin (I/F). *Signi¢cant inhibition of ami-
loride sensitive conductance. Stimulation of either wtCFTR,
L1480V-CFTR, E831X-CFTR or E1474X signi¢cantly en-
hanced CFTR whole cell Cl3 conductance. Figures in parenthe-
ses indicate numbers of experiments. *Signi¢cant inhibition of
GAmil ; #signi¢cant changes for CFTR dependent inhibition of
GAmil when compared with wtCFTR.
Fig. 3. Activation of CFTR Cl3 conductance (GCFTR) and inhi-
bition of amiloride sensitive ENaC conductance (GAmil) in the
absence or presence of NHERF1, NHERF2 and mutant
NHERF1 (NHERF1-E130X, NHERF1-S288/290/291A). CFTR
conductances (GCFTR, gray bars) are expressed as fractions of
the CFTR conductance activated in the absence of NHERF
(GCFTRÿH2O). Inhibition of amiloride sensitive conductances
(black bars) is expressed as % inhibition of the initial ENaC
conductance (GAmilÿcon3GAmilÿIBMX=Fors/GAmilÿcon). Activation
of CFTR whole cell Cl3 conductance and inhibition of ENaC
by stimulation of CFTR was signi¢cant for all combinations.
Figures in parentheses indicate numbers of experiments.
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3.2. NBF1, Cl3 conductance and inhibition of ENaC
In contrast to the CFTR PDZ-BD, which does not
seem to be essential for inhibition of ENaC by
CFTR, at least in Xenopus oocytes, we have reported
previously the requirement of an intact NBF1 of
CFTR [15]. On the other hand, we and others have
shown that Cl3 ions have to be present for inhibition
of ENaC by CFTR [18,19]. In the present experi-
ments, we aimed to identify the amino acid sequence
within NBF1 that may play an essential role for in-
hibition of ENaC. To that end, we tried to generate
CFTR-NBF1 mutants, which have lost their ability
to activate a Cl3 conductance, but still inhibit ENaC
or vice versa. The in vitro synthesized mutants car-
ried mutations (i) within Walker A and B motifs,
(ii) within stretches that are homologous to GTP
binding proteins and (iii) which are known to activate
GTP binding proteins [20]. We examined both abil-
ities of the CFTR mutants, (i) to generate a whole
cell Cl3 conductance upon stimulation with IBMX
and forskolin and (ii) to downregulate ENaC. Whole
cell conductances generated by each mutant were
compared with that of wtCFTR and are therefore
expressed as % of GwtCFTR (Fig. 4A, gray bars). In
this series of experiments, GwtCFTR was 56 þ 6.3 WS
(n = 9). wtCFTR inhibited amiloride sensitive Na
conductance from 24.2 þ 3.4 WS to 3.4 þ 0.5 WS
(n = 9). Amiloride sensitive Na conductances were
detected in all batches of oocytes expressing the var-
ious CFTR mutants, varying between 16 and 41 WS.
In order to be able to better compare the inhibitory
e¡ects of the various CFTR mutants on GAmil, the
fractional inhibition of GAmil is shown in Fig. 4
rather than the absolute amount of Na conductance
inhibited by CFTR. It is shown that all mutations
a¡ected the CFTR Cl3 channel function, due to re-
duced expression (e.g. vF508) or defective function
(e.g. G551D) of the mutant protein. The CFTR mu-
tants K646A, R487Q, G551D, D572N and K615A
did not generate signi¢cant CFTR Cl3 conductances.
These mutants also lost their ability to inhibit ENaC
(shown as % inhibition of the initial amiloride sensi-
tive Na conductance, black bars). The mutants
S466L, KH483/484AA, R516A and KK611/612AA
demonstrated a residual Cl3 channel function, which
was paralleled by a limited ability to downregulate
ENaC. The Cl3 conductance generated by these mu-
tants was inhibited by gluconate and demonstrated a
halide permeability sequence of Cl3vBr3s I3 (data
not shown). These results indicate that CFTR’s abil-
ity to generate a Cl3 conductance and to inhibit
ENaC are closely related and suggest that both prop-
erties cannot be separated by introducing mutations
into NBF1.
3.3. Halides conducted by CFTR inhibit ENaC
The whole cell conductance activated during stim-
ulation of CFTR was reduced from 43 þ 5.6 down to
19 þ 3.2. WS (n = 5), when extracellular Cl3 was re-
Fig. 4. (A) Impact of mutations located in NBF1 on the activa-
tion of whole cell Cl3 conductance (GCFTR) and CFTR depen-
dent inhibition of ENaC (GAmil). Activation of Cl3 conductan-
ces in Xenopus oocytes expressing wtCFTR and mutant CFTR
(expressed as % of GwtCFTR, gray bars) and inhibition of ami-
loride sensitive ENaC conductance (expressed as % inhib-
ition = GAmilÿcon3GAmilÿIBMX=Fors/GAmilÿcon, black bars). Figures
in parentheses indicate numbers of experiments. (B) Summary
of amiloride sensitive Na conductance (ENaC) inhibited dur-
ing activation of coexpressed CFTR. Inhibition of ENaC is sig-
ni¢cantly stronger in the presence of high Cl3 (101 mmol/l)
compared to low extracellular Cl3 (5 mmol). (C) Inhibition of
amiloride sensitive ENaC conductance by CFTR was similar
with either Cl3, Br3 or I3 present in the extracellular bath so-
lution. Stimulation of CFTR whole cell Cl3 conductance was
signi¢cant under all experimental conditions. Figures in paren-
theses indicate numbers of experiments.
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placed by gluconate. GENaC, inhibited upon stimula-
tion of CFTR with IBMX and forskolin, was signi¢-
cantly reduced when CFTR was stimulated in the
presence of low (5 mmol/l) extracellular Cl3 (Fig.
4B). This con¢rms previous results, demonstrating
that inhibition of ENaC by CFTR largely depends
on the CFTR Cl3 current [18]. In addition, we ex-
amined whether the inhibition of ENaC depends on
the halide present in the extracellular bath solution.
When bath Cl3 was replaced by either Br3 or I3, a
halide permeability sequence for the cAMP activated
Cl3 conductance of Cl3vBr3s I3 was obtained,
similar to what has been published previously [13].
CFTR inhibited ENaC in the presence of either Cl3,
Br3 or I3 in the extracellular bath solution (Fig. 4C).
Inhibition of ENaC by CFTR varied only slightly
but not signi¢cantly with the various halides present
in the bath solution. Taken together, these data sug-
gest that inhibition of ENaC by CFTR relies on the
anion current generated by CFTR and is largely in
the presence of the impermeable anion gluconate.
4. Discussion
4.1. No evidence for the role of PDZ domain proteins
during activation of CFTR in Xenopus oocytes
NHERF1 and NHERF2 are cytoplasmic phos-
phoproteins which are involved in PKA dependent
regulation of the Na/H antiporter NHE3 [21].
NHERF contains common sites for protein interac-
tion, called PDZ domains [12]. A domain comple-
mentary to these PDZ domains has been identi¢ed
at the C-terminal end of CFTR and binding of
NHERF1 and NHERF2 to CFTR has been shown
in subsequent experiments [6,9,11,12]. In airway epi-
thelial cells, CFTR binds to the recently identi¢ed
NERHF homologue EBP50, thereby anchoring
CFTR to the cytoskeleton via binding to ezrin [9].
However, coexpression of L2-adrenergic receptors,
E3KARP and ezrin together with CFTR only
slightly augmented activation of CFTR by isoproter-
enol [11]. Another study demonstrated PDZ interac-
tion of CFTR with cytoskeletal elements being essen-
tial for polarized distribution of CFTR in airway and
kidney epithelial cells [7]. Because ezrin may serve as
an PKA anchoring protein, it has been suggested
that interaction of NHERF (EBP50) with CFTR
and ezrin localizes PKA in close proximity to
CFTR and thereby promotes phosphorylation of
the R domain. In the present experiments we were
not able to demonstrate the requirement of the PDZ-
BD for the activation of CFTR in Xenopus oocytes.
Although the L1480V-CFTR mutant allows only
marginal binding of NHERF to CFTR [12], activa-
tion of L1480V-CFTR by IBMX and forskolin was
comparable to that of wtCFTR and even the N-ter-
minal half of CFTR (E831X) was still partially acti-
vated by increase in intracellular cAMP. It was a
surprising and rather unexpected result that
E1474X-CFTR caused a very large Cl3 conductance
which was signi¢cantly enhanced compared to
wtCFTR. Whether this is due to enhanced matura-
tion of the CFTR protein or due to a change of the
regulatory properties of CFTR remains currently un-
known. Moreover, coexpression of CFTR with wt or
mutant NHERF1 or NHERF2 did not a¡ect activa-
tion of CFTR. Therefore, our results do not support
a role of CFTR’s PDZ-BD or NHERF in PKA de-
pendent regulation of CFTR in Xenopus oocytes.
4.2. No evidence for the role of the CFTR PDZ-BD in
the inhibition of ENaC in Xenopus oocytes
The present experiments were undertaken in order
to examine the role of the CFTR PDZ-BD in the
downregulation of ENaC which has been described
extensively [13,14]. Lack of inhibition of ENaC by
mutant CFTR is probably the reason for enhanced
electrolyte absorption in cystic ¢brosis [1,14]. CFTR
binds to the sca¡olding protein EBP50 and is colo-
calized with other proteins such as YAP65 and the
non-receptor tyrosine kinase c-Yes. These proteins
may control epithelial Na transport [22]. A model
appears attractive in which CFTR inhibits ENaC
with the help of PDZ domain proteins, YAP65 and
non-receptor kinases. The present results, however,
do not support the idea of a CFTR/ENaC interac-
tion via PDZ domain proteins, since all mutants
lacking the CFTR PDZ-BD are still able to down-
regulate ENaC upon increase of intracellular cAMP.
Moreover, coexpression of NHERF1 or NHERF2
did not a¡ect the downregulation of ENaC by
CFTR. Taken together, the present experiments
show that inhibition of ENaC by CFTR in Xenopus
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oocytes does not occur via the C-terminal PDZ bind-
ing domain.
4.3. Cl3 transport and inhibition of ENaC are
intimately related
Previous work demonstrated that acute downregu-
lation of ENaC by CFTR requires an intact NBF1
and also depends on the Cl3 transport activated dur-
ing stimulation of CFTR [15]. This provokes the
question whether there is a speci¢c site within
NBF1 that is responsible for inhibition of ENaC or
whether it is the CFTR Cl3 conductance that is cru-
cial for the inhibition. However, activation of CFTR
Cl3 conductance requires a functional NBF1. We
found in a previous study that CFTR truncations
comprising NBF1 are able to inhibit ENaC slightly
albeit signi¢cantly. Some of these truncations did not
activate an additional Cl3 conductance upon stimu-
lation with IBMX/forskolin but induced an enhanced
baseline Cl3 conductance in these oocytes [15]. These
results and the present data suggest that the ability of
NBF1 containing CFTR truncations to inhibit
ENaC is largely augmented by a Cl3 current [15].
We therefore introduced mutations into NBF1 sites
which are essential for binding/hydrolysis of ATP
and GTP and which have homology to GTP binding
proteins such as Walker A (loop L1) (K464A,
S466L), switch I motif (KH483/484AA, R487A),
switch II motif (loop L4, G551D) and Walker B
(D572N) [23]. Furthermore, NBF1 sequences which
could potentially serve as activator sequences for
G proteins were mutated (KR598/600GA, KK611/
612AA, K615A). The region between K598 and
K615 contains two basic residues at the N-terminal
side and the sequence B-B-X-X-B at the C-terminus,
which is similar to structural determinants for the Gi
stimulating function of the active insulin-like growth
factor II receptor sequence [24]. All mutations exam-
ined here caused a reduced or even a complete loss of
the Cl3 conductance. To the same degree, the ability
of these mutants to downregulate ENaC was reduced
or completely lost, very similar to what has been
described previously [18]. We never observed an in-
dependent change of both CFTR properties. It sug-
gests that Cl3 transport is crucial for the inhibition
of ENaC. This is further con¢rmed by the Cl3 re-
placement experiments shown in Fig. 4B. However,
in contrast to the CFTR controlled release of ATP,
inhibition of ENaC is largely independent of the hal-
ide present in the bath solution [16].
How does the CFTR Cl3 conductance modulate
the activity of epithelial Na channels? As one pos-
sibility, the intracellular Cl3 concentration could
change and could directly a¡ect ENaC channel ac-
tivity [25]. However, assuming similar changes in the
intracellular Cl3 concentration occur in the sweat
duct epithelium during stimulation of CFTR, a direct
inhibition of ENaC by intracellular Cl3 appears un-
likely. It has been shown for the sweat duct epithe-
lium that activation of CFTR is paralleled by an
increase in ENaC conductance [5]. This suggests a
contribution of additional proteins, expressed di¡er-
entially in airways, colon and sweat duct. As another
possibility, the intracellular Cl3 concentration may
increase in airways and intestinal epithelium during
stimulation of CFTR but may fall in the sweat duct
epithelium. The currently available data are limited
and do not support large changes in intracellular Cl3
concentration during activation of CFTR in sweat
duct or airway/colonic epithelium [26^28]. Here,
more detailed analysis of the intracellular Cl3 con-
centration during activation of ion transport in all
three tissues will be required. Interestingly and in
contrast to airways and colon, CFTR is expressed
in both luminal and basolateral membrane of the
sweat duct epithelium and seems predominantly acti-
vated in basolateral membrane [26,29,30]. Cytosolic
Cl3 has been reported previously to regulate amilor-
ide sensitive Na channels in mouse salivary duct
cells via Cl3 sensitive trimeric G proteins [31]. How-
ever, in unpublished experiments performed in
Xenopus oocytes, we did not ¢nd any contribution
of GTP binding proteins or other Cl3 sensitive
proteins, such as nucleoside diphosphate kinase to
the regulation of ENaC by CFTR [32]. Future stud-
ies will have to demonstrate the link between
Cl3 conductance/concentration and regulation of
ENaC.
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